Measles Vaccines 2025

Measles vaccination programs began in the United States in 1963 and continue in every state and territory as of March 11, 2025. The U.S. Centers for Disease Control and Prevention (CDC) published the measles vaccination schedules for children and adults and has issued an advisory for international travelers visiting areas with a measles outbreak in 2025. 

In 2025, the CDC confirmed that if you are not sure if you or your travel companions are fully protected against measles, schedule an appointment to see your clinician at least six weeks before traveling so that you have enough time to get vaccinated with a measles, mumps, and rubella (MMR) vaccine. The CDC's Measles Clinical Presentation, Diagnosis, and Prevention Clinician Outreach and Communication Activity Call in 2023 included these presentations.

The European Medicines Agency (EMA) endorses various measles vaccines, including, but not limited to, M-M-RVaxPro and Priorix. The United Kingdom and Health Canada offer MMR vaccines to young children as part of vaccination schedules. Among those diagnosed with measles in Europe between the beginning of 2024 and early 2025 with information available, 25,503 (86%) were unvaccinated.

Measles Vaccines

The U.S. Food and Drug Administration (FDA) approved the intramuscular route of administration for M-M-R®II and ProQuad® vaccines on March 6, 2023. In addition, the FDA approved the Priorix vaccine to prevent MMR in individuals one year and older. The U.S. CDC stated on November 18, 2022, that the Priorx and M-M-R II® vaccines are considered fully interchangeable, including for all off-label recommended uses.

Merck & Co. M-M-R®II, a Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II, is approved by the U.S. FDA for use in people 12 months and older. And Proquad® is approved for children ages 1 through 12 who may also get the MMR and Varicella Virus vaccines.

Priorix - Is licensed in the USA and over 100 countries for use in individuals aged 9 or 12 months, according to a 1- or 2-dose schedule, depending on the country. Priorix protects people against MMR. The CDC's MMR Vaccine Work Group presented: Overview of Measles by Ms. Lynn Bahta and Overview of GSK's Priorix MMR Vaccine by Remon Abu-Elyazeed, MD, Ph.D., U.S. Vaccines Medical and Clinical Affairs. 

Tresivac - This vaccine is available in India to prevent MMR. Serum Institute of India Ltd is the manufacturer.

Shanghai Institute of Biological Products released about 42 million MMR doses in China in 2020. 

Bio-MMR vaccine is offered in Brazil.

India MMR vaccine is offered to children.

MeasBio® (Biovac) in South Africa.

Indian Immunologicals Limited announced the approval from the Drugs Controller General of India to manufacture the Mabella Live Attenuated Measles-Rubella Vaccine for children. This measles vaccine was developed in collaboration with the Polyvac Institute of Vietnam.

Measles Vaccines in Europe

Over the years, the European Union has authorized several monovalent vaccines for measles, including Amunovax, Priorix, Priorix Tetra, Provarivax, R.O.R. Vax, Rouvax, Trivivac, Varilrix, and Varivax. 

Measles Vaccine Immunity

The U.S. CDC says two doses of MMR vaccine are 97% effective against measles, and people who receive MMR vaccination according to the vaccination schedule are usually considered protected for life against measles. A study published in 2021 found that within 10–15 years, the proportion of individuals with detectable anti-measles IgG in two groups: those vaccinated with two doses of the anti-MMR vaccine and those with a self-reported history of measles infection. The proportion was higher among vaccinated individuals (20%; GMT = 92.2) than among those with a self-reported history of measles (6%; GMT = 213.3; p < .0001).

Measles Vaccine Price

According to the U.S. CDC, measles vaccine prices range from $87.31 to $250.02 as of 2024. Additional measles vaccine prices and discount information are posted at InstantRx™.

Measles Vaccine Microarray Patch Delivery

Vaxxas published positive results in November 2023 from a human clinical trial involving its technology that enables (measles) vaccines to be applied to the skin using a small microarray patch instead of a traditional needle and syringe.

Measles Outbreaks 2025

Measles outbreak news is updated as of March 2025.